Marco Pirisinu: Highlights Potential of PDEVs in Drug Delivery
Marco Pirisinu, Director of Business Development at Jotbody, shared a post on LinkedIn:
“Hey everyone,
I recently came across a review discussing the potential of plant-derived extracellular vesicles (PDEVs) in drug delivery.
Some highlights:
• Natural Carriers: PDEVs naturally encapsulate bioactive molecules like proteins, lipids, and RNAs, which can synergize with therapeutic agents.
• Biocompatibility: Being plant-based, they exhibit low immunogenicity, reducing potential adverse reactions.
• Stability: PDEVs demonstrate resilience under various conditions, ensuring the integrity of encapsulated drugs.
• Scalability: Plants offer a sustainable and scalable source for vesicle production, facilitating large-scale applications.
These attributes make PDEVs a promising avenue for delivering a range of therapeutic agents, including small molecules, proteins, and nucleic acids.
I will also put the reference here“.
All the latest news in the World of Hematology featured in Hemostasis Today.
-
Apr 19, 2026, 05:14Mehmet N. Cizmeci: Neuroimaging in Preterm Infants With Intraventricular Hemorrhage Is Evolving
-
Apr 19, 2026, 04:47Test Your Hematology Knowledge with ASH Questions and Answers – ASH
-
Apr 19, 2026, 04:26Priyanka Raheja: Happy World Haemophilia Day from The Royal London Haemophilia Centre
-
Apr 18, 2026, 18:55William Aird: Ferritin as a Probability Signal
-
Apr 18, 2026, 18:54Abdulla A. Damluji: OCEANIC-STROKE Trial Analysis and Its Clinical and Market Implications
-
Apr 18, 2026, 18:29Vasee Moorthy: Join WHO Clinical Trial Course Launch at Stand With Science 2026
-
Apr 18, 2026, 18:28Holly O’Byrne: Improving Hemorrhagic Shock Care With a Patient Centered System
-
Apr 18, 2026, 18:26Sthanu Subramanian: CVST as The ‘Great Masquerader’ with Normal Initial CT
-
Apr 18, 2026, 18:25Priyanka Raheja: Sharing the Final Analysis From the Roctavian Phase 1/2 Study